LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
© LexDana · beta
LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged crispr · clear

PTAB

One Battle After Another: Broad Institute Wins at PTAB in CRISPR Dispute

Written by : Eric Furman, Ph.D. and Alistair J. McIntyre Key Takeaways : Interference proceedings, though increasingly rare, are heavily evidence-based and determine which party is the first inventor when two or more applicants claim the same patentable…

April 7, 2026·PTAB·3 min read
Data: FDA Orange & Purple Books · prosecution & litigation metadata · read-only.